Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
This document is in .pdf format and can be downloaded at the bottom of this page.
In this issue:
Drug safety advice
- Fibrates: new prescribing advice
- Lumiracoxib: hepatotoxicity
- Ceftriaxone: incompatibility with calcium-containing solutions
- Codeine: very rare risk of side-effects in breastfed babies
- St John’s wort: interactions with all antiepileptics
Yellow Card scheme update
- please report suspected reactions with herbal medicines
Hot topics
- Illegal herbal remedies that contain Aristolochia: vigilance needed
- Nasal decongestants that contain pseudoephedrine or ephedrine: sales restrictions
Stop Press
- Moxifloxacin: hepatotoxicity and serious skin reactions—prescribing update
- Co-proxamol withdrawal: reminder to prescribers
- Ecoflac infusion solutions: risk of air embolism
Other information from the MHRA
- Optometrists: independent prescribing
- Patient Information Leaflets: improving quality
- MHRA conference: ‘Combating Counterfeit Medicines’
Drug Safety Update: Volume 1, Issue 4, November 2007 
